bioept (BIOC)表示,它允许Plus (PSTV)在其临床试验和商业中使用CNSide测试,等待监管部门的批准。Plus Therapeutics (PSTV)的股票在反...查看全文
不入流资讯2023-09-08 20:23
$Plus Therapeutics(PSTV)$ Plus Therapeutics jumps 23% premarket after obtaining a nonexclusive license and option for exclusivity for patients receiving CNS radiotherapy查看全文
牛股小红书2022-04-06 13:10
$Plus Therapeutics(PSTV)$ 表示,已扩大与Dassault Systèmes(OTCPK:DASTY)旗下公司Medidata的合作伙伴关系,以加快Rhenium-186纳米脂质体治疗复发性胶质母细胞瘤的2期临床试验的注册速度,降低临床试验成本。
该合作关系将使用Medidata的合成控制臂平台,该平台以美国食品和药物管理局认可...查看全文
薛定锷之猫2021-11-23 09:49
$Plus Therapeutics(PSTV)$ 所谓的放射性纳米疗法治复发性GBM,大概率失败?终于明白当初TOCA为啥也是找晚期复发性GBM下手了。市值2千万,真正的仙股啊。查看全文
$Plus Therapeutics(PSTV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-061858 Size: 4 KB 网页链接
$Plus Therapeutics(PSTV)$ 内部交易: 2021-10-26,CFO,Sims Andrew John Hugh MacIntyr ,买入,2000普通股, $1.67
$Plus Therapeutics(PSTV)$ 内部交易: 2021-10-26,CEO,HEDRICK MARC H ,买入,2500普通股, $1.66
$Plus Therapeutics(PSTV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-061723 Size: 4 KB 网页链接
$Plus Therapeutics(PSTV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-061724 Size: 4 KB 网页链接
$Plus Therapeutics(PSTV)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-21-051444 Act: 34 Size: 610 KB 网页链接
$Plus Therapeutics(PSTV)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-21-051432 Act: 34 Size: 5 MB 网页链接
$Plus Therapeutics(PSTV)$ 8-K Current report, items 3.03, 5.03, and 9.01 Accession Number: 0001193125-21-277718 Act: 34 Size: 357 KB 网页链接
$Plus Therapeutics(PSTV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-056096 Size: 5 KB 网页链接
$Plus Therapeutics(PSTV)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0001193125-21-270847 Act: 34 Size: 248 KB 网页链接